EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieMultizentrische StudieOpen Access · CC BY-NC 4.0

Women with persistent atrial fibrillation need more than pulmonary vein isolation: personalised extra-pulmonary vein ablation strategy vs. pulmonary vein isolation alone in the TAILORED-AF trial

Isabel Deisenhofer iD, Julien Seitz iD, Marie-Sophie Nguyen-Tu iD, Sabine Lotteau iD, Clément Bars, Jean-Paul Albenque iD, Sonia Busch iD, Edouard Gitenay iD, Stavros Mountantonakis iD, Antoine Roux, Jérôme Horvilleur iD, Babe Bakouboula iD und 18 weitere

Europace · 2025

DOI: 10.1093/europace/euaf281 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Europace, 2025. Verfasst von Isabel Deisenhofer und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrophysiology, Technical University of Munich (TUM), German Heart Centre Munich, Lazarettstr. 36, 80636 Munich, Germany. Hauptthemen laut MEDLINE: Atrial Fibrillation, Pulmonary Veins, Catheter Ablation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Volta Medical.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

There is still conflicting evidence if women with persistent atrial fibrillation (AF) profit from a pulmonary vein isolation (PVI) plus strategy. We evaluated the efficacy of a spatio-temporal dispersion-targeted ablation strategy in women from the TAILORED-AF trial. Methods and results In TAILORED-AF, 370 patients were randomised to either a personalised, artificial intelligence (AI)-guided tailored ablation or to PVI-only. AF substrate mapping data and 12-month ablation outcomes were compared between women and men. Overall, 21% patients were female (70.4 ± 6.9 vs. 64.5 ± 8.5 years for men, P < 0.001). While spatio-temporal dispersion extent was similar between groups, left atrial low-voltage surface area (<0.2 mV) was significantly larger in women (P < 0.01). In women, the single-procedure freedom from AF (76% vs. 50%, log-rank P < 0.001) and any atrial arrhythmia (56% vs. 38%, log-rank P < 0.05) were significantly superior to PVI alone with a tailored procedure. In the PVI-only group, the single-procedure freedom from AF (50% vs. 70%, log-rank P < 0.001) and any atrial arrhythmia (38% vs. 61%, log-rank P < 0.001) were significantly lower in women. After a tailored ablation, no significant differences were observed between women and men regarding freedom from AF (76% vs. 91%, log-rank P = 0.07) or any atrial arrhythmia (56% vs. 62%, log-rank P = 0.69) free survival.

Conclusion

Compared to men, PVI-only in women with persistent AF leads to a significantly lower freedom from atrial arrhythmia. A personalised spatio-temporal dispersion-targeted ablation strategy led to a higher rate of freedom from any atrial arrhythmia than standard PVI after a single procedure in women and comparable outcomes between women and men. Registration identification clinicaltrials.gov NCT04702451

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationPulmonary VeinsCatheter AblationHumansFemaleMiddle AgedMaleAgedSex FactorsTreatment OutcomeAction PotentialsArtificial IntelligenceRecurrenceTime FactorsHeart Rate

Stichwörter der Autor:innen

Artificial intelligenceCatheter ablationWomenatrial fibrillation

Autor:innen und Institutionen

  • Department of Electrophysiology, Technical University of Munich (TUM), German Heart Centre Munich, Lazarettstr. 36, 80636 Munich, Germany.
  • Hôpital Saint Joseph, Marseille, France.
  • Volta Medical, Marseille, France.
  • Department of Cardiology-Heart Rhythm Management, Clinique Pasteur, Toulouse, France.
  • Department of Electrophysiology, Herz-Zentrum Bodensee, Konstanz, Germany.
  • Northwell Cardiovascular Institute, New Hyde Park, NY, USA.

ORCID-Profile: Isabel Deisenhofer, Julien Seitz, Marie-Sophie Nguyen-Tu, Sabine Lotteau, Jean-Paul Albenque, Sonia Busch, Edouard Gitenay, Stavros Mountantonakis, Jérôme Horvilleur, Babe Bakouboula, Saumil Oza, Antoine Lepillier, Yves Guyomar, Francis Bessière, Jaap Jan Smit, Anil Rajendra, Daniel H Cooper, Tom De Potter, Christian De Chillou, Seth Goldbarg, Atul Verma, Gustavo Morales, John D Hummel, Jérôme Kalifa

Förderung

  • Volta Medical

Zitieren

APA

Deisenhofer, I., Seitz, J., Nguyen-Tu, M. S., Lotteau, S., Bars, C., Albenque, J. P., Busch, S., Gitenay, E., Mountantonakis, S., Roux, A., Horvilleur, J., Bakouboula, B., Oza, S., Abbey, S., Theodore, G., Lepillier, A., Guyomar, Y., Bessière, F., Smit, J. J., …, & Kalifa, J. (2025). Women with persistent atrial fibrillation need more than pulmonary vein isolation: personalised extra-pulmonary vein ablation strategy vs. pulmonary vein isolation alone in the TAILORED-AF trial. Europace. https://doi.org/10.1093/europace/euaf281

Vancouver

Deisenhofer I, Seitz J, Nguyen-Tu MS, Lotteau S, Bars C, Albenque JP, et al. Women with persistent atrial fibrillation need more than pulmonary vein isolation: personalised extra-pulmonary vein ablation strategy vs. pulmonary vein isolation alone in the TAILORED-AF trial. Europace. 2025. doi:10.1093/europace/euaf281

BibTeX
@article{Deisenhofer2025,
  author = {Deisenhofer, Isabel and Seitz, Julien and Nguyen-Tu, Marie-Sophie and Lotteau, Sabine and Bars, Clément and Albenque, Jean-Paul and Busch, Sonia and Gitenay, Edouard and Mountantonakis, Stavros and Roux, Antoine and Horvilleur, Jérôme and Bakouboula, Babe and Oza, Saumil and Abbey, Selim and Theodore, Guillaume and Lepillier, Antoine and Guyomar, Yves and Bessière, Francis and Smit, Jaap Jan and Rajendra, Anil and Cooper, Daniel H and Rashid, Haroon and De Potter, Tom and De Chillou, Christian and Goldbarg, Seth and Verma, Atul and Morales, Gustavo and Milpied, Paola and Hummel, John D and Kalifa, Jérôme},
  title = {Women with persistent atrial fibrillation need more than pulmonary vein isolation: personalised extra-pulmonary vein ablation strategy vs. pulmonary vein isolation alone in the TAILORED-AF trial},
  journal = {Europace},
  year = {2025},
  doi = {10.1093/europace/euaf281}
}
Kostenlos starten →